G42 produces Sinopharm’s vaccine, America gets the answer of CCP’s vaccine gets the answer of Covid-19 origins

Group 42 (G42) joined World Sustainable Business Forum (WSBF) as strategic AI partner on 3 May 2023. G42 would share their view of the Artificial Intelligence (AI) and digital economy through the platform of WSBF. WSBF would bring together government and business leaders to shape the future sustainability issues.

Group 42 is an artificial intelligence and cloud computing organisation. Its main office is in Abu Dhabi, United Arab Emirates. This organisation involves business in healthcare, finance, oil and gas, aviation, hospitality and the government sector in several countries.

According to an article from Reuters on 2 November 2020, G42 worked with a Chinese state-owned pharmaceutical company. They ran a final trial test of the COVID-19 vaccine in the United Arab Emirates in 2020.

In January 2021, G42 entered a joint venture with China National Pharmaceutical Group (Sinopharm) to produce Covid-19 vaccine in Abu Dhabi. Another report stated that AstraZeneca partners with G42 Healthcare to have drug production in Abu Dhabi in December 2022.

However, Miles Guo warns the world about the Covid-19 virus and the vaccine. He said vaccines would do more harm to our body and change our DNA. They are the bioweapons developed by the CCP to destroy humanity.

In that case, if the America wants to find out the origin of the Covid-19 virus, they should look at where G42 vaccine comes from, they should hold the information from Sinopharm.

That means it would access the information from the CCP about where the CCP’s vaccine comes from. The Select Subcommittee on the Coronavirus Pandemic should investigate G42 about that.

Now, Miles Guo is the victim of the CCP’s infiltration of the US justice system, the Congress must step in to his prosecution to find out the black hands behind the system.

Picture of Aussie Brief News
Aussie Brief News

Go to First Page and Get the Latest News.

Translator: MsAnn
Design&editor: Fusu

Leave a Reply

Your email address will not be published. Required fields are marked *